# Comparison Between Mirtazapine and Megestrol for the Control of Anorexia-cachexia in Cancer Patients in Palliative Care.

> **NCT03283488** · PHASE2 · COMPLETED · sponsor: **University of Sao Paulo** · enrollment: 52 (actual)

## Conditions studied

- Cachexia; Cancer
- Anorexia

## Interventions

- **DRUG:** Mirtazapine
- **DRUG:** Megestrol

## Key facts

- **NCT ID:** NCT03283488
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-26
- **Primary completion:** 2022-02-02
- **Final completion:** 2022-02-02
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2023-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03283488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03283488, "Comparison Between Mirtazapine and Megestrol for the Control of Anorexia-cachexia in Cancer Patients in Palliative Care.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03283488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*